Clinical Trial Update: Hypofractionated Brain Radiation In EGFR Mutated Adenocarcinoma Cranial Disease (Hybrid) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating hypofractionated brain radiation for stage IV EGFR-mutated non-small cell lung cancer with brain metastases; the status is currently un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer with Brain Metastases

Snippet

Sponsor: Sichuan Provincial People's Hospital | Conditions: Stage IV EGFR Mutated NSCL With Brain Metastases | Phase 3 | Status: UNKNOWN